NEXT Oncology expands phase I program with VCS partnership

NEXT Oncology and Virginia Cancer Specialists have joined forces, launching NEXT Virginia, a cancer clinic, in September 2021.

This partnership will also help expand VCS’s phase I and developmental therapeutics cancer research program and bring the latest in new agents and anticancer treatments to the VCS Research Institute.

The expanded phase I program will begin this fall, while the stand-alone NEXT Virginia clinic, adjacent to Virginia Cancer Specialists, is built.

NEXT Virginia is headed by Alex Spira, co-director of the VCS Research Institute, who is the site’s clinical director and CEO. Spira is also the director of the VCS thoracic and phase I program and a clinical assistant professor at John Hopkins.

NEXT Oncology has relationships with both Texas Oncology and Virginia Cancer Specialists, both of which are practices in the US Oncology Network. The new clinic will be located at 8613 Lee Highway in Fairfax.

See article